The HIV-1 Screening Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global HIV-1 Screening Tests market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the HIV-1 Screening Tests global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While ELISA segment is altered to a % CAGR between 2022 and 2028.
Global key companies of HIV-1 Screening Tests include Siemens AG (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S), Danaher Corporation (US), and Thermo-Fisher Scientific Inc (US), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
HIV-1 Screening Tests market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
ELISA
Rapid Tests
Home Access Dried Blood Spot
Market segment by Application, can be divided into
Hospital
Clinic
Others
Market segment by players, this report covers
Siemens AG (Germany)
Roche Diagnostics (Switzerland)
Abbott Laboratories (U.S)
Danaher Corporation (US)
Thermo-Fisher Scientific Inc (US)
Merck KGaA (Germany)
Becton, Dickinson and Company (US)
Hologic, Inc (US)
Alere Inc (US)
Bio-Rad Laboratories (US)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe HIV-1 Screening Tests product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of HIV-1 Screening Tests, with revenue, gross margin and global market share of HIV-1 Screening Tests from 2019 to 2022.
Chapter 3, the HIV-1 Screening Tests competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and HIV-1 Screening Tests market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe HIV-1 Screening Tests research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of HIV-1 Screening Tests
1.2 Classification of HIV-1 Screening Tests by Type
1.2.1 Overview: Global HIV-1 Screening Tests Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global HIV-1 Screening Tests Revenue Market Share by Type in 2021
1.2.3 ELISA
1.2.4 Rapid Tests
1.2.5 Home Access Dried Blood Spot
1.3 Global HIV-1 Screening Tests Market by Application
1.3.1 Overview: Global HIV-1 Screening Tests Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global HIV-1 Screening Tests Market Size & Forecast
1.5 Global HIV-1 Screening Tests Market Size and Forecast by Region
1.5.1 Global HIV-1 Screening Tests Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global HIV-1 Screening Tests Market Size by Region, (2017-2022)
1.5.3 North America HIV-1 Screening Tests Market Size and Prospect (2017-2028)
1.5.4 Europe HIV-1 Screening Tests Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific HIV-1 Screening Tests Market Size and Prospect (2017-2028)
1.5.6 South America HIV-1 Screening Tests Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa HIV-1 Screening Tests Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 HIV-1 Screening Tests Market Drivers
1.6.2 HIV-1 Screening Tests Market Restraints
1.6.3 HIV-1 Screening Tests Trends Analysis
2 Company Profiles
2.1 Siemens AG (Germany)
2.1.1 Siemens AG (Germany) Details
2.1.2 Siemens AG (Germany) Major Business
2.1.3 Siemens AG (Germany) HIV-1 Screening Tests Product and Solutions
2.1.4 Siemens AG (Germany) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Siemens AG (Germany) Recent Developments and Future Plans
2.2 Roche Diagnostics (Switzerland)
2.2.1 Roche Diagnostics (Switzerland) Details
2.2.2 Roche Diagnostics (Switzerland) Major Business
2.2.3 Roche Diagnostics (Switzerland) HIV-1 Screening Tests Product and Solutions
2.2.4 Roche Diagnostics (Switzerland) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Roche Diagnostics (Switzerland) Recent Developments and Future Plans
2.3 Abbott Laboratories (U.S)
2.3.1 Abbott Laboratories (U.S) Details
2.3.2 Abbott Laboratories (U.S) Major Business
2.3.3 Abbott Laboratories (U.S) HIV-1 Screening Tests Product and Solutions
2.3.4 Abbott Laboratories (U.S) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Abbott Laboratories (U.S) Recent Developments and Future Plans
2.4 Danaher Corporation (US)
2.4.1 Danaher Corporation (US) Details
2.4.2 Danaher Corporation (US) Major Business
2.4.3 Danaher Corporation (US) HIV-1 Screening Tests Product and Solutions
2.4.4 Danaher Corporation (US) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Danaher Corporation (US) Recent Developments and Future Plans
2.5 Thermo-Fisher Scientific Inc (US)
2.5.1 Thermo-Fisher Scientific Inc (US) Details
2.5.2 Thermo-Fisher Scientific Inc (US) Major Business
2.5.3 Thermo-Fisher Scientific Inc (US) HIV-1 Screening Tests Product and Solutions
2.5.4 Thermo-Fisher Scientific Inc (US) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Thermo-Fisher Scientific Inc (US) Recent Developments and Future Plans
2.6 Merck KGaA (Germany)
2.6.1 Merck KGaA (Germany) Details
2.6.2 Merck KGaA (Germany) Major Business
2.6.3 Merck KGaA (Germany) HIV-1 Screening Tests Product and Solutions
2.6.4 Merck KGaA (Germany) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Merck KGaA (Germany) Recent Developments and Future Plans
2.7 Becton, Dickinson and Company (US)
2.7.1 Becton, Dickinson and Company (US) Details
2.7.2 Becton, Dickinson and Company (US) Major Business
2.7.3 Becton, Dickinson and Company (US) HIV-1 Screening Tests Product and Solutions
2.7.4 Becton, Dickinson and Company (US) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Becton, Dickinson and Company (US) Recent Developments and Future Plans
2.8 Hologic, Inc (US)
2.8.1 Hologic, Inc (US) Details
2.8.2 Hologic, Inc (US) Major Business
2.8.3 Hologic, Inc (US) HIV-1 Screening Tests Product and Solutions
2.8.4 Hologic, Inc (US) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Hologic, Inc (US) Recent Developments and Future Plans
2.9 Alere Inc (US)
2.9.1 Alere Inc (US) Details
2.9.2 Alere Inc (US) Major Business
2.9.3 Alere Inc (US) HIV-1 Screening Tests Product and Solutions
2.9.4 Alere Inc (US) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Alere Inc (US) Recent Developments and Future Plans
2.10 Bio-Rad Laboratories (US)
2.10.1 Bio-Rad Laboratories (US) Details
2.10.2 Bio-Rad Laboratories (US) Major Business
2.10.3 Bio-Rad Laboratories (US) HIV-1 Screening Tests Product and Solutions
2.10.4 Bio-Rad Laboratories (US) HIV-1 Screening Tests Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Bio-Rad Laboratories (US) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global HIV-1 Screening Tests Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 HIV-1 Screening Tests Players Market Share in 2021
3.2.2 Top 10 HIV-1 Screening Tests Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 HIV-1 Screening Tests Players Head Office, Products and Services Provided
3.4 HIV-1 Screening Tests Mergers & Acquisitions
3.5 HIV-1 Screening Tests New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global HIV-1 Screening Tests Revenue and Market Share by Type (2017-2022)
4.2 Global HIV-1 Screening Tests Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global HIV-1 Screening Tests Revenue Market Share by Application (2017-2022)
5.2 Global HIV-1 Screening Tests Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America HIV-1 Screening Tests Revenue by Type (2017-2028)
6.2 North America HIV-1 Screening Tests Revenue by Application (2017-2028)
6.3 North America HIV-1 Screening Tests Market Size by Country
6.3.1 North America HIV-1 Screening Tests Revenue by Country (2017-2028)
6.3.2 United States HIV-1 Screening Tests Market Size and Forecast (2017-2028)
6.3.3 Canada HIV-1 Screening Tests Market Size and Forecast (2017-2028)
6.3.4 Mexico HIV-1 Screening Tests Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe HIV-1 Screening Tests Revenue by Type (2017-2028)
7.2 Europe HIV-1 Screening Tests Revenue by Application (2017-2028)
7.3 Europe HIV-1 Screening Tests Market Size by Country
7.3.1 Europe HIV-1 Screening Tests Revenue by Country (2017-2028)
7.3.2 Germany HIV-1 Screening Tests Market Size and Forecast (2017-2028)
7.3.3 France HIV-1 Screening Tests Market Size and Forecast (2017-2028)
7.3.4 United Kingdom HIV-1 Screening Tests Market Size and Forecast (2017-2028)
7.3.5 Russia HIV-1 Screening Tests Market Size and Forecast (2017-2028)
7.3.6 Italy HIV-1 Screening Tests Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific HIV-1 Screening Tests Revenue by Type (2017-2028)
8.2 Asia-Pacific HIV-1 Screening Tests Revenue by Application (2017-2028)
8.3 Asia-Pacific HIV-1 Screening Tests Market Size by Region
8.3.1 Asia-Pacific HIV-1 Screening Tests Revenue by Region (2017-2028)
8.3.2 China HIV-1 Screening Tests Market Size and Forecast (2017-2028)
8.3.3 Japan HIV-1 Screening Tests Market Size and Forecast (2017-2028)
8.3.4 South Korea HIV-1 Screening Tests Market Size and Forecast (2017-2028)
8.3.5 India HIV-1 Screening Tests Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia HIV-1 Screening Tests Market Size and Forecast (2017-2028)
8.3.7 Australia HIV-1 Screening Tests Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America HIV-1 Screening Tests Revenue by Type (2017-2028)
9.2 South America HIV-1 Screening Tests Revenue by Application (2017-2028)
9.3 South America HIV-1 Screening Tests Market Size by Country
9.3.1 South America HIV-1 Screening Tests Revenue by Country (2017-2028)
9.3.2 Brazil HIV-1 Screening Tests Market Size and Forecast (2017-2028)
9.3.3 Argentina HIV-1 Screening Tests Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa HIV-1 Screening Tests Revenue by Type (2017-2028)
10.2 Middle East & Africa HIV-1 Screening Tests Revenue by Application (2017-2028)
10.3 Middle East & Africa HIV-1 Screening Tests Market Size by Country
10.3.1 Middle East & Africa HIV-1 Screening Tests Revenue by Country (2017-2028)
10.3.2 Turkey HIV-1 Screening Tests Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia HIV-1 Screening Tests Market Size and Forecast (2017-2028)
10.3.4 UAE HIV-1 Screening Tests Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global HIV-1 Screening Tests Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global HIV-1 Screening Tests Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market HIV-1 Screening Tests Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global HIV-1 Screening Tests Revenue (USD Million) by Region (2017-2022)
Table 5. Global HIV-1 Screening Tests Revenue Market Share by Region (2023-2028)
Table 6. Siemens AG (Germany) Corporate Information, Head Office, and Major Competitors
Table 7. Siemens AG (Germany) Major Business
Table 8. Siemens AG (Germany) HIV-1 Screening Tests Product and Solutions
Table 9. Siemens AG (Germany) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Roche Diagnostics (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 11. Roche Diagnostics (Switzerland) Major Business
Table 12. Roche Diagnostics (Switzerland) HIV-1 Screening Tests Product and Solutions
Table 13. Roche Diagnostics (Switzerland) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Abbott Laboratories (U.S) Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories (U.S) Major Business
Table 16. Abbott Laboratories (U.S) HIV-1 Screening Tests Product and Solutions
Table 17. Abbott Laboratories (U.S) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Danaher Corporation (US) Corporate Information, Head Office, and Major Competitors
Table 19. Danaher Corporation (US) Major Business
Table 20. Danaher Corporation (US) HIV-1 Screening Tests Product and Solutions
Table 21. Danaher Corporation (US) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Thermo-Fisher Scientific Inc (US) Corporate Information, Head Office, and Major Competitors
Table 23. Thermo-Fisher Scientific Inc (US) Major Business
Table 24. Thermo-Fisher Scientific Inc (US) HIV-1 Screening Tests Product and Solutions
Table 25. Thermo-Fisher Scientific Inc (US) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Merck KGaA (Germany) Corporate Information, Head Office, and Major Competitors
Table 27. Merck KGaA (Germany) Major Business
Table 28. Merck KGaA (Germany) HIV-1 Screening Tests Product and Solutions
Table 29. Merck KGaA (Germany) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Becton, Dickinson and Company (US) Corporate Information, Head Office, and Major Competitors
Table 31. Becton, Dickinson and Company (US) Major Business
Table 32. Becton, Dickinson and Company (US) HIV-1 Screening Tests Product and Solutions
Table 33. Becton, Dickinson and Company (US) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Hologic, Inc (US) Corporate Information, Head Office, and Major Competitors
Table 35. Hologic, Inc (US) Major Business
Table 36. Hologic, Inc (US) HIV-1 Screening Tests Product and Solutions
Table 37. Hologic, Inc (US) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Alere Inc (US) Corporate Information, Head Office, and Major Competitors
Table 39. Alere Inc (US) Major Business
Table 40. Alere Inc (US) HIV-1 Screening Tests Product and Solutions
Table 41. Alere Inc (US) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Bio-Rad Laboratories (US) Corporate Information, Head Office, and Major Competitors
Table 43. Bio-Rad Laboratories (US) Major Business
Table 44. Bio-Rad Laboratories (US) HIV-1 Screening Tests Product and Solutions
Table 45. Bio-Rad Laboratories (US) HIV-1 Screening Tests Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global HIV-1 Screening Tests Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global HIV-1 Screening Tests Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of HIV-1 Screening Tests by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. HIV-1 Screening Tests Players Head Office, Products and Services Provided
Table 50. HIV-1 Screening Tests Mergers & Acquisitions in the Past Five Years
Table 51. HIV-1 Screening Tests New Entrants and Expansion Plans
Table 52. Global HIV-1 Screening Tests Revenue (USD Million) by Type (2017-2022)
Table 53. Global HIV-1 Screening Tests Revenue Share by Type (2017-2022)
Table 54. Global HIV-1 Screening Tests Revenue Forecast by Type (2023-2028)
Table 55. Global HIV-1 Screening Tests Revenue by Application (2017-2022)
Table 56. Global HIV-1 Screening Tests Revenue Forecast by Application (2023-2028)
Table 57. North America HIV-1 Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 58. North America HIV-1 Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 59. North America HIV-1 Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 60. North America HIV-1 Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 61. North America HIV-1 Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 62. North America HIV-1 Screening Tests Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe HIV-1 Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe HIV-1 Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe HIV-1 Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe HIV-1 Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe HIV-1 Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe HIV-1 Screening Tests Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific HIV-1 Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific HIV-1 Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific HIV-1 Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific HIV-1 Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific HIV-1 Screening Tests Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific HIV-1 Screening Tests Revenue by Region (2023-2028) & (USD Million)
Table 75. South America HIV-1 Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 76. South America HIV-1 Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 77. South America HIV-1 Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 78. South America HIV-1 Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 79. South America HIV-1 Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 80. South America HIV-1 Screening Tests Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa HIV-1 Screening Tests Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa HIV-1 Screening Tests Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa HIV-1 Screening Tests Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa HIV-1 Screening Tests Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa HIV-1 Screening Tests Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa HIV-1 Screening Tests Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. HIV-1 Screening Tests Picture
Figure 2. Global HIV-1 Screening Tests Revenue Market Share by Type in 2021
Figure 3. ELISA
Figure 4. Rapid Tests
Figure 5. Home Access Dried Blood Spot
Figure 6. HIV-1 Screening Tests Revenue Market Share by Application in 2021
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Others Picture
Figure 10. Global HIV-1 Screening Tests Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global HIV-1 Screening Tests Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global HIV-1 Screening Tests Revenue Market Share by Region (2017-2028)
Figure 13. Global HIV-1 Screening Tests Revenue Market Share by Region in 2021
Figure 14. North America HIV-1 Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe HIV-1 Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific HIV-1 Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America HIV-1 Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa HIV-1 Screening Tests Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. HIV-1 Screening Tests Market Drivers
Figure 20. HIV-1 Screening Tests Market Restraints
Figure 21. HIV-1 Screening Tests Market Trends
Figure 22. Siemens AG (Germany) Recent Developments and Future Plans
Figure 23. Roche Diagnostics (Switzerland) Recent Developments and Future Plans
Figure 24. Abbott Laboratories (U.S) Recent Developments and Future Plans
Figure 25. Danaher Corporation (US) Recent Developments and Future Plans
Figure 26. Thermo-Fisher Scientific Inc (US) Recent Developments and Future Plans
Figure 27. Merck KGaA (Germany) Recent Developments and Future Plans
Figure 28. Becton, Dickinson and Company (US) Recent Developments and Future Plans
Figure 29. Hologic, Inc (US) Recent Developments and Future Plans
Figure 30. Alere Inc (US) Recent Developments and Future Plans
Figure 31. Bio-Rad Laboratories (US) Recent Developments and Future Plans
Figure 32. Global HIV-1 Screening Tests Revenue Share by Players in 2021
Figure 33. HIV-1 Screening Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 34. Global Top 3 Players HIV-1 Screening Tests Revenue Market Share in 2021
Figure 35. Global Top 10 Players HIV-1 Screening Tests Revenue Market Share in 2021
Figure 36. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 37. Global HIV-1 Screening Tests Revenue Share by Type in 2021
Figure 38. Global HIV-1 Screening Tests Market Share Forecast by Type (2023-2028)
Figure 39. Global HIV-1 Screening Tests Revenue Share by Application in 2021
Figure 40. Global HIV-1 Screening Tests Market Share Forecast by Application (2023-2028)
Figure 41. North America HIV-1 Screening Tests Sales Market Share by Type (2017-2028)
Figure 42. North America HIV-1 Screening Tests Sales Market Share by Application (2017-2028)
Figure 43. North America HIV-1 Screening Tests Revenue Market Share by Country (2017-2028)
Figure 44. United States HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe HIV-1 Screening Tests Sales Market Share by Type (2017-2028)
Figure 48. Europe HIV-1 Screening Tests Sales Market Share by Application (2017-2028)
Figure 49. Europe HIV-1 Screening Tests Revenue Market Share by Country (2017-2028)
Figure 50. Germany HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific HIV-1 Screening Tests Sales Market Share by Type (2017-2028)
Figure 56. Asia-Pacific HIV-1 Screening Tests Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific HIV-1 Screening Tests Revenue Market Share by Region (2017-2028)
Figure 58. China HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South Korea HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America HIV-1 Screening Tests Sales Market Share by Type (2017-2028)
Figure 65. South America HIV-1 Screening Tests Sales Market Share by Application (2017-2028)
Figure 66. South America HIV-1 Screening Tests Revenue Market Share by Country (2017-2028)
Figure 67. Brazil HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East and Africa HIV-1 Screening Tests Sales Market Share by Type (2017-2028)
Figure 70. Middle East and Africa HIV-1 Screening Tests Sales Market Share by Application (2017-2028)
Figure 71. Middle East and Africa HIV-1 Screening Tests Revenue Market Share by Country (2017-2028)
Figure 72. Turkey HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. UAE HIV-1 Screening Tests Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Methodology
Figure 76. Research Process and Data Source